Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence

Recruiting now · Not applicable

Conditions studied: Thromboembolic Venous Disease

In brief

The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specific populations: patients under 50 years of age, men and women (5 year recurrence), as well as cancer patients (all ages) (1 year recurrence).

Key facts

Study ID

NCT04297085

Run by

University Hospital, Brest

People needed

3400

Starts

2020-05-28

Expected to finish

2050-04-01

Last updated by the study team

2026-06-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject aged 18 or over, or a minor with the consent of the parents and the minor, presenting with a thromboembolic venous disease
• 50 and under or any age if active cancer
• Affiliated to social security
• Accepting to participate in the study.

You may not qualify if…

• Inability to communicate (comprehension disorder).
• Refusal to participate.

Where it is running

• CHRU Brest — Brest, France (enrolling)
• HIA Clermont Tonnerre Brest — Brest, France (enrolling)
• CH Morlaix — Morlaix, France (enrolling)
• CH de Cornouaille — Quimper, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.